NEJM with two early release articles. One by cardiologist Eric Topol, and the other questioning whether Celebrex and other COX-2’s have similar cardiovascular risk.
Vioxx debacle: A class effect?
Real physician voices, twice a week
Free, and one click to unsubscribe.
Keep reading
The Podcast
Latest episodes
Most popular
Your living will could get you too much care, or too little
Heart and brain got the investment; the musculoskeletal system did not
Memory loss is not normal aging, and waiting costs the treatment window
Stop calling it burnout: COVID denial and the wounds ER doctors carry
Fired for seeing her own patients: moral injury and life after medicine
Doctors lose hours to admin work that AI or an assistant could do
Hospice waits on a court order when no family can speak for you
